Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
Background: Negative symptoms and diminished cognitive ability are also considered as core features of schizophrenia. There are many studies in which negative symptoms and cognitive impairments are individually treated with atypical antipsychotic in comparison with either a placebo or a typical anti...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wolters Kluwer Medknow Publications
2014-01-01
|
| سلاسل: | Industrial Psychiatry Journal |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2014;volume=23;issue=1;spage=27;epage=35;aulast=Kumar |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|